Next-generation neurotherapeutics
Leveraging the power of music and technology to redefine what's possible in brain health
Millions of people live with persistent walking deficits.
We exist to positively impact the lives of those living with these deficits around the world.
Walking disability significantly decreases independence, reduces quality of life, increases falls, and adds to healthcare system burden. In the U.S. alone, over 100 million people have a walking disability caused by a neurologic injury or disease. But it doesn’t have to be this way. MedRhythms exists to rewrite this story by developing transformative and innovative therapeutics through the combination of advances in neuroscience and technology.
Our Technology Platform
MedRhythms is pioneering the development of next-generation neurotherapeutics designed to improve walking, mobility and related functional outcomes via a proprietary, patented technology platform.
This platform is used to develop products rooted in an evidence-based intervention known as Rhythmic Auditory Stimulation (RAS), which, research has shown, can improve walking impairments caused by neurologic diseases and injuries1.
Our platform combines sensors, software, and music with advanced neuroscience to target neural circuitry. We are developing a pipeline of digital therapeutics across a range of neurological conditions, including stroke, multiple sclerosis and Parkinson’s disease.
- Thaut, M., & Abiru, M. (2010). Rhythmic Auditory Stimulation in Rehabilitation of Movement Disorders: A Review Of Current Research. Music Perception, 27(4), 263-269. doi: https://doi.org/10.1525/mp.2010.27.4.263
30 years of academic research show potential for RAS to improve walking
In the last three decades, over 50 clinical research studies have been published supporting the efficacy of music to improve movement by harnessing the potential of RAS to promote clinically meaningful changes in functional outcomes.
30,000 hours of clinical experience
Our clinicians have used RAS and other evidence-based music interventions to deliver over 30,000 hours of direct patient care. In 2017, the company recognized an opportunity to leverage technology as a significantly more scalable modality, in view of growing demand from people suffering from neurologic gait disorders and the limited number of trained clinicians.
Our Co-Founder and CEO, Brian Harris, is a board-certified Neurologic Music Therapist and one of only 350 professionals globally with advanced training in the clinical application of neuroscience and music.
He founded MedRhythms as a Neurologic Music Therapy practice at Spaulding Rehabilitation Hospital, one of the top rehabilitation hospitals in the country, and has grown the practice to be the most comprehensive Neurologic Music Therapy practice in the U.S.
World’s first prescription music platform
MedRhythms has entered into a collaboration with Universal Music Group to provide patients using our platform with access to the most diverse and culturally rich collection of music ever assembled.
Through this collaboration, MedRhythms aims to provide patients with therapy via music that they know and enjoy.
Our digital therapeutics use music content that is curated and screened via a patented process, which carefully selects and customizes interventions to each user.
The process initially analyzes the content for the right characteristics to make it therapeutically valuable for the patients and, once this step is complete, curates, augments, and individualizes clinical interventions for each patient.
Passionate team
We are powered by a team of passionate, dedicated leaders who are committed to our culture and mission.
- Clinical expertise – we know what works
- Technical expertise – we know how to build it
- Business expertise – we know how to get it into patients’ hands